Low-dose Radiotherapy Plus Tislelizumab in Combination With Afatinib for Neoadjuvant Treatment of Surgically Resectable Head and Neck Squamous Carcinoma
Clinical trial NCT06494189 · COMPLETED
Trial details
- NCT number
- NCT06494189
- Sponsor
- West China Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-31
- Primary completion
- 2025-04-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.